Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 2024Advanced ScienceOpen Access

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJi-Hoon HanSKSeohyun KimYHYeong Ha Hwang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Han et al. (2024) studied this question.

synapsesocial.com/papers/68e6d587b6db643587652a2dhttps://doi.org/10.1002/advs.202308662
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapy2026 · 4 citations
  2. 2Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy2026
  3. 3Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis2024 · 59 citations
  4. 4Assessing persistent antitumor immunity induced by tumor derived extracellular vesicle hydrogel vaccination without neoantigen identification2026
  5. 5Immunomodulatory roles of tumor-derived extracellular vesicles and their therapeutic implications in breast cancer2025 · 1 citations